explore
Previous article:
Duchenne breakthrough therapy leaves behind pioneering families
Next article: As pharma fights Medicare drug negotiation, hospitals, docs silent
Next article: As pharma fights Medicare drug negotiation, hospitals, docs silent
focus
explore
-
Why the drug industry's warnings on the IRA's impact fall short
2025-08-26 23:18 -
Departing Stanford president retracts two papers
2025-08-26 22:12 -
Winners, losers from Medicare’s list of drugs subject to price talks
2025-08-26 21:30 -
Appeals court upholds limits to abortion pill
2025-08-26 21:26 -
How the messy conversation about Dolly changed bioethics
2025-08-26 21:17 -
Fed up with FDA, ALS advocates consider a take
2025-08-26 21:07